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Abstract 
Ethnopharmacological relevance: Coptidis Rhizoma (CR, Chinese name is Huanglian) has
been used in treating infectious and inflammatory diseases for two thousand years in 
Traditional Chinese Medicine (TCM). Its related pharmacological basis for the therapeutics 
has been studied intensively, but CR can be also used for vomiting of “dampness-heat type or
acid regurgitation” due to “liver-fire attacking stomach” in TCM, which symptoms seem to 
link the hepatic and biliary disorders, yet details in the therapies of liver diseases and 
underlying mechanism(s) remain unclear. Aim of the Study: in the present study, 
hepatoprotective effect of Coptidis Rhizoma aqueous extract (CRAE) and its possible 
mechanism were studied in rats intoxicated with carbon tetrachloride (CCl4). Materials and 
Methods: Sprague-Dawley (SD) rats aged 7 weeks old were intraperitoneally injected with 
CCl4 at a dose of 1.0 ml/kg as a 50% olive oil solution. The rats were orally given the CRAE
at doses of 400, 600, 800 mg/kg and 120 mg/kg berberine body weight (BW) after 6 hours of 
CCl4 treatment. At 24 hours after CCl4 injection, samples of blood and liver were collected 
and then biochemical parameters and histological studies were carried out. Results: the 
results showed that CRAE and berberine inhibited significantly the activities of alanine 
aminotransferase (ALT) and aspartate aminotransferase (AST) and increased the activity of 
superoxide dismutase (SOD). Observation on the hepatoprotective effect of berberine was 
consistent to that of CRAE. Conclusion: the study is the first time to demonstrate that CRAE 
has hepatoprotective effect on acute liver injuries induced by CCl4, and the results suggest 
that the effect of CRAE against CCl4-induced liver damage is related to antioxidant property.
Keywords: Coptidis Rhizoma aqueous extract; Carbon tetrachloride; Aspartate 
aminotransferase; Alanine aminotransferase; Superoxide dismutase; Liver histopathology.
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Abbreviations: CR, Coptidis Rhizoma; CRAE, Coptidis Rhizoma aqueous extract; CCl4, 
Carbon tetrachloride; AST, Aspartate aminotransferase; ALT, Alanine aminotransferase; 
SOD, Superoxide dismutase; SD rats, Sprague-Dawley rats; H & E staining, Hematoxylin 
and eosin staining.
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1. Introduction
Coptidis Rhizoma (CR, Chinese name is Huanglian) is a Chinese herbal medicine used 
as a clearing heat and detoxifying agent, and has been used to treat syndromes incurred by 
damp-heat, fire or toxicity in Traditional Chinese Medicine (TCM) for two thousand years,
which can be conceived as inflammatory diseases. Extensive studies exhibited that CR has 
many pharmacological actions with strong clinical implications, including antibacterial, 
antiviral, antiinflammatory, antineoplastic, antihypertensive, antioxidative, antihyperglycemic 
and cholesterol-lowering effects (Chang and But, 2004; Choi, et al., 2007; Kim, et al., 2008; 
Fukuda, et al., 1998; Li, et al., 2000; Sanae, et al., 2001; Yokozawa, et al., 2003, 2004).
Traditionally, CR can be used for vomiting with “dampness-heat type” or “acid regurgitation 
due to liver-fire attacking stomach” in TCM, whose symptoms seem to be linked with the 
hepatic and biliary disorders, yet its therapeutic potential remains unexplored. In TCM 
clinical practice, CR is a key component in many TCM formulae. Typically, Huanglian Jiedu
decoction (or Oren- gedoku-to in Japanese or JT-15, including Coptidis Rhizoma, Radix 
Scutellariae, Cortex Phellodendri, and Frucuts Gardeniae) has been used for the therapies of 
hepatitis and liver dysfunction in addition to gastric ulcers, dermatitis, dementia, and 
cerebrovascular diseases in Japan (Itoh, 2001) and has intensively studied for scientific basis 
of hepatitis and liver dysfunction in Japan (Ohta, et al., 1997, 1998, 2004), but whether CR 
has liver protection or not is unknown. Berberine, due to the phytochemical analysis, was the 
main ingredient in CR (Xu et al., 2004). It was reported that herbs with high content of 
berberine exhibit preventive effect or curative effect on liver damage (Nadkarni, 1976, Gilani 
and Janbaz, 1995; Janbaz and Gilani, 2000), indicating that CR is potential for the treatment 
of liver injury and hepatitis. According to the history of CR use, clinical indications of 
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CR-containing composite formulae, and clinical indications of berberine-containing plant
species in other traditional medicine, we have used CR to prescribe for various liver diseases 
in TCM clinical practice in China (Feng et al., 2008). It is interesting to explore the exact 
effect of CR on liver damage and underlying mechanisms.
It was reported that the changes associated with CCl4-induced liver damage are similar to 
that of acute viral hepatitis (Rubinstein, 1962), drug/chemicals-induced hepatopathy and 
oxidative stress (Recknagel et al., 1989; Kadiiska et al., 2000), so CCl4-induced 
hepatotoxicity model is frequently used for the investigation of hepatoprotective effects of 
drugs and plant extracts. CRAE has shown to ameliorate renal oxidative injury in vivo and in 
vitro (Yokozawa et al 1999, 2004, 2005). Previous study revealed that preventive effect of 
huanglian-jie-du-tang extract on progression of CCl4-induced acute liver injury in rats is 
related to its antioxidant properties (Ohta et al, 1997, 1998, 2001).  Whether CRAE 
contributes to its antioxidant effects on CCl4-induced acute liver injury in rats is not known 
yet.
In the present study, CCl4 was therefore introduced to induce liver damage on 
experimental animal model, and the curative effect of CRAE was examined via determining 
serum Alanine aminotransferase (ALT), aspartate aminotransferase (AST), serum and tissue 
superoxide dismutase (SOD) level as well as hitopathological study. Phytochemistry of 
CRAE was also analyzed via High performance liquid chromatogram (HPLC) in this study.
The experimental results demonstrated the potential effects of CRAE in protecting liver 
function, reducing oxidative stress, and improving histopathological structures in the rat
model of CCl4–induced liver damage. The study not only provides helpful information for
the application of CRAE in liver disease, but also promotes the understanding of the
pharmacological mechanisms of CRAE in the acute toxic liver injury.
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2. Materials and methods
2.1. Plant materials and extraction procedures
Crude herb, Coptidis Rhizoma (Coptis chinensis Franch.) was collected from Sichuan 
province, China and authenticated under the guidance of The Pharmacopeia of China (2005).
Plant materials were dried under shade and cut into small pieces before extraction. For the 
preparation of CRAE, one gram of crude CR was boiled in 10ml of distilled water at 100ْ C 
for 1 hour. Total was 500g of crude CR. The solution was percolated through filter paper 
(Whatman, pleated filter grade 597 1/2, 4–7 μm) and then sterilized by filtration through a 0.2
μm pore filter (Minisart®-plus, Sartorius), while the residue was further extracted under the 
same condition once. The filtrates collected from the extraction were combined and 
evaporated to dryness by vacuum at temperature. The dry extract powder obtained (40g) was 
stored in –20 ºC freezer and used in following experiments. 
The chemical profile of CRAE was recorded by high performance liquid chromatography 
(HPLC) with photodiode array (PDA) detection. CRAE powder (26.6 mg) was accurately 
weighed and dissolved in 9 ml acidified methanol (a mixture of fuming hydrochloric acid and 
methanol in 1:100 proportion). The solution was heated in a 60 oC water bath for 15 min, 
followed by ultrasonication for 30 min. The solution was then filtered by using a 0.45 µm 
Millex Syringe filter unit and subjected to HPLC analysis. The HPLC analytical system is 
composed of a Waters 600s solvent delivery system coupled with a 717 plus autosampler 
(with injection volume at 10 L) and a 996 photodiode array detector. A reverse-phase C18
column (Alltech Alltima HP C18, 250 mm × 4.6 mm, 5 µm)eluting with a mobile phase 
(acetonitrile:25 mM potassium dihydrogen phosphate in H2O (25: 75)) in an isocratic manner
and at a flow rate of 1 ml/min was employed. The eluate was monitored at the wavelength of 
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345 nm. The column temperature was kept at 24 C. Berberine is used as the reference
standard for identifying and quantifying the major component in CRAE. The whole analysis 
was duplicated for confirmation.  
Atomic absorption spectroscopic (AAS) analysis of five toxic heavy metals, including 
arsenic, cadmium, chromium, lead and mercury, was preformed on PerkinElmer Analyst 800 
atomic absorption spectrometer with autosampler.
2.2. Drugs and chemical test agents
Alanine aminotransferase (ALT) and aspartate aminotransferase (AST) test kits were 
purchased from Stanbio, USA. SOD assay kit was from Biovision, USA. Carbon 
tetrachloride (CCl4), olive oil and berberine, were purchased from Sigma, USA. Standards of 
arsenic, cadmium, chromium, lead and mercury were purchased from the Sigma, USA.
2.3. Test Animals
Adult male SD rats 7 weeks weighing 250 ± 20 g were obtained from animal centre of 
The University of Hong Kong. The animals left for 2 days for acclimatization to animal room 
conditions were maintained on standard pellet diet and water ad libitum at a temperature of 
20–25 C under a 12 h light/dark cycle throughout the experiment. The food was 
withdrawn on the day before the experiment, but free access of water was allowed. The rats 
were randomly assigned. A minimum of 8 animals were used in each group. All animals 
received human care and study protocols complied with the guidelines of the animal centre of 
the University of Hong Kong. Throughout the experiments, animals were processed 
according to the suggested international ethical guidelines for the care of laboratory animals. 
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2.4. CCl4-induced acute liver damage model in rats and CRAE treatment
The animals were randomly divided into five groups, that is, normal, CCl4 alone, and 
400, 600, 800 mg/kg BW CRAE and 120 mg/kg berberine BW treatment on CCl4 groups,
containing eight rats in each. Rats were intraperitoneally (i.p.) injected with CCl4 at a dose of 
1.0 ml/kg as a 50 % olive oil solution according to the previously reported methods with 
some modification (Moghaddam, et al. 1998; Feng, et al. 2000) and control ones with the 
same dose of olive oil. Our previous clinical practice showed the therapeutic effect of CRAE 
on liver injury, infectious hepatitis and even cancer (Feng, et al., 2008), the dosage of raw
herb we use in clinic was about 30~50 gram in single use or 9-18 gram in formulation. 
Excellent effect and no toxicity were observed in our clinical practice. The result and dosage 
in present study fit our clinical study, that is, if we use conversion table to compute the 
clinical dosage from the animal dosage, 400~800 mg/kg, it will be 25~50 gram, near our 
clinical study. On the other hand, lower than 400mg/kg may have no effect in our dose 
screening in rats. Hence, the CRAE was dissolved in distilled water at a concentration of 400, 
600 or 800 mg/kg BW orally administered to rats injected with or without CCl4 treatment at 6
hours after CCl4 exposure. The control rats were orally given the same volume of distilled 
water. These animals were fasted with free access to water throughout the experiment. 
Twenty-four hours after the CCl4 administration, blood samples were withdrawn by 
cardiac puncture when the animals had been anaesthetized with ketamine /xylazine mixture 
(ketamine 67mg/kg, xylazine 6mg/kg, i.p). The animals were sacrificed by an overdose of 
pentobarbitone (Phenobarbital 200mg/kg, i.p) or diethyl ether immediately after blood 
collection. Blood samples collected in heparinized tubes were centrifuged at 3000 × g for 10 
min to obtain serum. Serum samples were used to determine SOD as well as to test ALT and 
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AST activities. On the other hand, the liver of each rat was promptly removed and used to 
determine the tissue level SOD and for further histopathological study.
2.5. Serum ALT and AST analysis
Biocon standard kits and an auto-analyzer (Hitachi 736-60, Tokyo, Japan) (UV-Rate) 
were used to measure serum ALT and AST activities in serum samples according to the 
method published before (Wilkinson et al., 1972). Values are derived based on the 
“absorptivity micromolar extinction coefficient” of NADH at 340 nm. ALT and AST 
activities expressed in terms of units per liter (U/L) are the amount of enzyme oxidizing one 
μmol/L of NADH per minute.
2.6. SOD levels in serum and liver tissues
The sensitive SOD assay kit (SOD Assay Kit-WST) utilizes mitochondrial activity that 
produces a water-soluble formazan dye upon reduction with superoxide anion. The rate of the 
reduction with a superoxide anion is linearly related to the xanthine oxidase (XO) activity, 
and is inhibited by SOD. Therefore, the inhibition activity of SOD determined by a 
colorimetric method was used for the determination of the serum and liver SOD level in this 
study.
Serum and liver homogenate collected from test animals were for measurement of SOD 
in blood and liver tissues. Procedure was carried out by according to SOD Assay Kit-WST 
Technical Manual (Dojindo Laboratories, Kumamoto, Japan). 
2.7. Histopathological studies
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
11
For the histopathological study, the livers of eight animals in each group were 
immediately removed after autopsy and the tissues were fixed in 10% buffered formaldehyde 
solution for a period of at least 24 h. The paraffin sections were then prepared (Automatic 
Tissue Processor, Lipshaw) and cut into 5 μm thick sections by a Leica RM 2016 rotary 
microtome (Leica Instruments Ltd., Shanghai, China). The sections were stained with 
hematoxylin and eosin staining (H & E staining) and then mounted with Canada balsam 
(Sigma, USA). The degree of liver damage was examined under the microscope (Leica 
Microsystems Digital Imaging, Germany). The images were taken using Leica DFC 280 
CCD camera at original magnification of 10×10. Through grading the liver sections 
numerically to assess their histological features, acute liver injury was evaluated by three 
independent researchers. Vacuolation, nuclei, hepatocyte necrosis, inflammatory cell 
infiltration and central vein and portal triad were used as criteria, and a combined score of 
histological features was given for each liver section. The parameters were graded from score 
0 to 6, with 0 indicating no abnormality, 1–2 indicating mild injury, 3–4 indicating moderate 
injury and 5–6 with severe liver injury (Wills and Ahsa, 2006; Wang et.al., 2008).
2.8. Statistical analysis
The data obtained were analyzed by one-way of variance (ANOVA) and 
Student–Newman–Kelus post hoc tests for the significant interrelation between the groups. 
Data were expressed as mean ± standard error of the mean and were analyzed with SPSS, 
version 11.5 software. Differences between group means were calculated by a one-way 
analysis of variance. Values of P< 0.05 were considered to be statistically significant. 
3. Results 
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3.1. Quality control of CRAE
The crude herb of huanglian was identified by morphological characteristics of CR 
(Coptis chinensis Franch.) according to The Pharmacopeia of China (2005) and the voucher 
specimens (no. CR20060616) was deposited in the Herbarium of School of Chinese Medicine, 
The University of Hong Kong. The plant and crude herb were shown in Figure 1A and B.
The HPLC chemical profile of CRAE is shown in Fig. 1 C. Nine characteristic 
chromatographic peaks were recorded at 345 nm. The chemical identity of the peak at 14.98
min was confirmed as berberine by chromatographic peak matching of berberine reference 
standard at 15.02 min (Fig. 1 D) and the similar UV-Visible spectra with max at 345 nm. A 
calibration curve of berberine reference standard showing a good linearity over the 
concentration range from 10 to 160 µg/ml with a regression coefficient at r2 = 0.9999 (Fig. 1 
E) was obtained. The content of berberine in CRAE powder was determined to be 20.3 mg in 
100 mg of the powder (i.e., 20.3 % weight by weight) with deviation less than 1% in 
duplicated analysis. Among other eight peaks, five (including the peaks 4, 5, 6, 7 and 8) 
showed the similar UV spectra of berberine with max at 345 nm.
As shown in Table 1, the contents of five heavy metals (Arsenic, Cadmium, Chromium, 
Lead, and Mercury) in CRAE determined from the AAS analysis fell in the range less than 
the maximum limit (20 ppm or g/g) as regulated in China Pharmacopeia (2005) and the 
World Health Organization (WHO). The amount of the five harmful elements in CRAE is in 
the safe range for herbal test use.
3.2. Liver protective effects of CRAE and berberine on acute liver damage in rats
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Compared with the normal group, the ALT activities in serum of the control treated with 
CCl4 at an i.p. dose of 1.0 ml/kg was significantly elevated (P<0.01) after 24 h. While 
treatment with 400 mg/kg BW, CRAE decreased remarkably the levels of serum ALT in rats 
treated with CCl4 though higher than the normal rats. The orally administered CRAE at a 
higher dose of 600 mg/kg BW and 800 mg/kg BW could significantly reduce the serum ALT 
level and restored them to normal levels when compared with rats treated with CCl4 control 
(P<0.01). This result showed that the oral treatment with 800, 600 and 400 mg/kg BW of 
CRAE could inhibit the elevated ALT activities in rats intoxicated with CCl4 in a 
dose-dependent manner (Table. 2).
Compared with the normal group, serum AST activities were significantly elevated 
(P<0.01) by 6 h after the CCl4 treatment. Post-administration of 600 and 800 mg/kg BW 
CRAE significantly decreased the AST activities in serum in contrast to CCl4-treated rats 
(P<0.05, P<0.01), but 400 mg/kg BW CRAE did not show effect on the AST levels in the 
CCl4-treated rats (Table.2).
Significantly reduced serum ALT and AST levels in liver damage rats treated with 
berberine 120 mg/kg were also observed (Table. 2).
3.3. Effect of CRAE and berberine on the levels of serum SOD and liver homogenate SOD 
activities in acute liver damage of rats
The inhibition rate of serum SOD activities in control rats treated with CCl4 alone was 
remarkably decreased after 24 h (P<0.01) compared with the normal ones, which showed the 
injured liver functions by CCl4. While treated with 800, 600, 400 mg/kg BW CRAE and 120 
mg/kg BW berberine, the inhibition rates of SOD were significantly elevated (P<0.01) 
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compared with the control rats, especially the high dose at 800 mg/kg BW could restore the 
value to the normal level (Table 2). Liver homogenate SOD activities were similar to serum 
expression (Table 2). 
3.4. Effect of CRAE and berberine on histopathological changes of liver in acute liver 
damage of rats
The histological changes associated with the hepatoprotective activity in three dosages of 
CRAE and berberine basically supported the measuring of the serum enzyme activities. There 
was no abnormal appearance or histological changes in the liver of normal control rats, which 
received olive oil only (Fig. 2 A). CCl4 administration caused classical damage in the rat liver 
at 24 h, as demonstrated by severe hepatocyte necrosis, inflammatory cells infiltration, fatty 
degeneration, hemorrhage, and hydropic degeneration (Fig. 2 B), vacuole generation and 
microvascular steatosis were frequently observed. The administration of BW at dose of 800, 
600 and 400 mg/kg could largely rescue the severity of CCl4-induced liver intoxication, in 
which the high dose at 800 mg/kg was most effective (Fig. 2 C-E). The histological patterns
showed dose dependant improvements for fatty change, necrosis and lymphocyte infiltration 
in contrast to treatment with CCl4 showing an obvious formation of necrosis. Improvement
results were observed in liver section from animals treated with 120 mg/kg berberine (Fig 2 
F). The scoring of histological damage was displayed in Table 2. 
4. Discussion and conclusions
Three clues led us to study CR against liver diseases: traditional use and our TCM daily 
practices for liver diseases (Feng et al., 2008), liver protective effects of 
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Hunaglian-containing composite formula (Huanglian je du decoction) (Ohta et al., 1997, 
1998, 2004), and berberis aristata (major compound is berberine which is the same as CR) is 
used for liver disease in South Asian areas, only showed preventive, but not curative effects 
on liver damage in rats treated with CCl4 (Gilani and Janbaz, 1995; Janbaz and Gilani, 2000). 
We assume that CR is a main effective herb in Huanglian je du decoction for liver protection 
and CR should possess curative effects on liver damage. The aim of the present study was to 
investigate the potential hepatoprotective effects of Coptidis Rhizoma aqueous extract 
(CRAE) on the free radical damage of liver caused by CCl4 in rats.
Firstly, quality control was conducted for the raw herb of CR and CRAE to guarantee the 
reliability of our experimental results. The plant materials of Coptidis rhizhoma, Chinese 
name is “Haunglian”, have three species. Rhizoma of Coptis Chinensis Franch, one of the 
species, was chosen for our study due to its plentiful cultivation in China and most popular in 
TCM practice. Miao et al. (1997) have shown that when Coptidis rhizoma, Scutellariae radix, 
and Phellodendri cortex are extracted with 50% methanol, the Scutellariae radix extract has 
much higher O2
−-scavenging activity than the Phellodendri cortex extract, while the Coptidis 
rhizoma extract has little O2
−-scavenging activity. Yokozawa et al. (1997) have reported that 
although the boiled water extract of Coptidis rhizoma, Gardeniae frucuts, Scutellariae radix
or Phellodendri cortex inhibits lipid peroxidation induced by H2O2 in rat liver homogenates, 
the Coptidis rhizoma extract has the highest inhibitory activity, followed in the order of 
strength by the Gardeniae frucut extract > the Scutellariae radix extract > the Phellodendri 
cortex extract. We assume that water extract of CR should possess better bioactivities 
according to the above two reports. In addition, the water extract of CR is clinically applied 
form, and thus being used in our study. The yield amount of CRAE obtained from raw herb 
was similar to previous reports (Li, et al., 2000; Yokozawa, et al., 2004). The consistency of 
chemical composition in the CRAE is important in safeguarding the reliability of the research
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results. The chemical profile of CRAE was recorded by the RP-HPLC/PDA analysis. The
HPLC chemical profile could be delineated by the measurement of relative retention times of 
major characteristic peaks using berberine as a marker. The resulting chromatogram was used 
as a standard for assessment of all extracts used in the current study. The HPLC chemical 
profile of the CRAE was similar to the previous report (Li, et al., 2000). As toxic heavy 
metals may induce toxicity including liver damage (Duffus, 2002; Wang, et al., 2007) and 
traditional Chinese medicines have drawn attention by its heavy metals (Cooper K, et al., 
2007), five commonly found toxic metals, including aresenic, cadimum, chromium, lead and 
mercury were analyzed and their contents in CRAE were in safe range set by the 
Pharmacopeia of China (2005) and WHO. 
Many drugs or chemical substances are known to cause hepatic injuries, such as 
acetaminophen, CC14, D-galactosamine (GalN), aflatoxins and dimethylnitrosamine (DMN),
among which, liver injury induced by CCl4 is the best-characterized system of the 
xenobiotic-induced hepatotoxicity and a commonly used model for screening the drugs with 
anti-hepatotoxicity and/or hepatoprotective activity (Brattin et al., 1985). CCl4-induced liver 
damage, a free radical damage model, results from oxidative stress that could directly injure 
hepatocellular membrane by lipid peroxidation, followed by a series of cascades of cellular 
events such as the massive release of inflammatory mediators or cytokines, which eventually 
lead to liver injuries (Pessayre, 1995; Dizdaroglu, et al., 2002; Higuchi and Gores, 2003). 
Superoxide dismutase (SOD) is one of the most important antioxidative enzymes, whose 
activities decrease after CCl4 injection. Therefore we selected SOD as parameter for the 
antioxidative effects of CR. The present study showed that CCl4 administration caused severe 
acute liver damage in rats, which was demonstrated by significant elevation of serum AST, 
ALT levels, decreased SOD activities (Table 2), and classic histopathological changes
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(Fig.2), indicating that CCl4-induced liver damage in animal model can be used to evaluate 
the curative effect of CRAE.
All data in our study consistently demonstrated that CRAE treatment at a dose of 800,
600 and 400 mg/kg BW had a potent protective effect against oxidative stress and acute liver 
damage induced by CCl4 in rats, as revealed by remarkable elevation of SOD activities in the 
liver and serum (Table 2). Additionally, CRAE could ameliorate acute liver damage to a high 
degree, as demonstrated by reduction of serum ALT and AST levels and the improvement of 
the histopathological changes (Table 2, 3 and Fig.2). Apart from mild hydropic degeneration 
of hepatocytes, the liver had a nearly normal appearance in CCl4-treated rats simultaneously 
treated with CRAE at a dose of 800 mg/kg BW (Fig.2 and Table 3). The results also indicated 
a remarkable elevation of SOD activities in the liver and serum of rats for CRAE treatment at 
24 h after CCl4 administration. It was previously reported that CRAE effectively scavenged 
the NO radical in-vitro (Yokozawa et al 2000, 2004), so the action mechanisms underlying 
hepatoprotection of CRAE may be related to both its radical scavenging properties and 
indirect effects as a regulator of antioxidative systems in which more details should be 
figured out in the future.
Phytochemical analysis indicated that berberine is also a major compound in CRAE (see 
Fig. 1 C and 1 D). Previous studies have demonstrated that berberine showed 
hepatoprotection possibly through inhibitory action on hepatic drug metabolizing enzymes, 
cytochrome P450s (Gilani and Janbaz, 1995; Janbaz and Gilani 2000), but no evident 
curative effect of berberine against CCl4-induced acute liver damage is investigated before. 
Our present study shows that 120 mg/kg of berberine can significantly decrease the elevation 
of serum AST and SLT level induced by CCl4 treatment in animal model, and the recovery of 
SOD activity both in serum and tissue indicates berberine as an antioxidant agent in liver 
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protection. This convinces our observation on CRAE’s action on liver damage and further the 
knowledge that berberine may be the major active component in CRAE when it was used for 
liver diseases. Berberine 120 mg/kg BW which is the equal of CRAE 600 mg/kg BW 
(calculated by about 20% of berberine in CRAE according to Fig.1) displays good liver 
protective effect (effect close to CRAE 800 mg/kg BW). Detailed dose-effect relationship 
and bioavailability of berberine on hepatoprotective effect need to be further studied. 
In conclusion, the study is the first time to demonstrate that CRAE has an impressive 
hepatoprotective effect on acute liver injuries induced by CCl4, which might be considered to 
be therapeutic effect in clinical situations. Berberine may be the major active component in 
CRAE for hepatoprotective effect. As a possible mechanism, CRAE could alleviate liver 
injury through antioxidative effects. On the other hand, the model of CCl4-induced hepatic 
injury in the rat is similar to many features of acute hepatitis induced by toxicants and virus, 
hence our results could partially explicate therapeutic principle for CRAE in TCM clinical 
application, suggesting that CRAE could be used as a potential new drug for acute liver 
injury. 
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1Ye, et al. Table 1 
Table 1. Content (ppm or µg/g) of five selected toxic metals in CRAE
Heavy metals   Mean ± RSD (%)     Calibration correlation cofactor (%)
Aresenic -0.26±32.54% 99.95
Cadimum 0.48±18.90% 99.91
Chromium 0.01±8.67% 99.82
Lead -0.04±8.84% 99.90
Mercury 0.14±39.69% 99.40
Table
2Ye, et al. Table 2
Table 2 Effect of CRAE and berberine on CCl4-induced liver damage in rat ( Mean±S.D., 
N=8)
#<p<0.05 compared with normal group
##p<0.01 compared with normal group
*p<0.05 compared with CCl4 control group
**p<0.01 compared with CCl4 control group
Group ALT(U, in
serum)
AST(U, in 
serum)
SOD (%, in 
serum)
SOD (%, in 
tissue)
Normal 19.877±7.34 61.759±30.62 77.26±0.11 72.42±5.89
Control 133.27±32.11## 342.11±55.27## 10.80±0.21
## 9.32±5.31##
CRAE
400 mg/kg
66.26±11.24**## 366.22±52.16## 26.70±0.23*# 21.61±4.97*#
CRAE
600 mg/kg
41.17±10.66** 155.39±30.24*# 40.30±0.15*# 46.22±4.46*#
CRAE
800 mg/kg
23.29±12.76** 20.78±10.77** 73.70±0.20** 70.63±6.54**
Berberine
120 mg/kg
26.06±7.48** 23.48±5.91** 75.21±1.79** 68.42±8.13**
3Ye, et al. Table 3
Table 3 Microscopic observation on CRAE and berberine against CCl4-induced acute liver 
damage (Mean ± S.D., n=8)
Group Vacuolation nuclei hepatocyte 
necrosis
inflammatory 
cell 
infiltration
central 
vein and 
portal 
triad
combined 
score
Normal 0.4±0.3 1.0±0.7 0.5±0.2 0.6±0.3 1.1±0.6 0.5±0.3
Control 5.0±0.6## 0.7±0.2 4.2±0.8## 3.9±1.6## 0.5±0.3# 4.9±0.5##
CRAE 400 mg/kg 4.2±1.1* 0.8±0.6 2.2±1.7* 2.8±1.3* 1.3±0.8* 3.6±1.4*
CRAE 600 mg/kg 3.0±1.0** 1.1±0.3 2.1±1.5** 2.1±1.3** 1.1±0.6* 2.7±0.9**
CRAE 800 mg/kg 1.9±0.7** 1.2±0.6 1.5±1.2** 1.3±0.9** 0.9±0.5 1.7±0.6**
Berberine
120 mg/kg
1.7±1.3** 1.8±0.2 1.4±0.4** 1.2±0.5** 1.1±0.4* 1.6±0.8**
#<p<0.05 compared with normal group
##p<0.01 compared with normal group
*p<0.05 compared with CCl4 control group
**p<0.01 compared with CCl4 control group
1Ye, et al. Fig.1
Figure 1.
Figure
2Ye, et al. Fig.2
Figure 2.
3Figure captions
Figure 1. Huanglian identification and HPLC chemical profile of CRAE. A. The species of
CR plant is Coptis Chinensis Franch. B. Raw herb of CR. C. The HPLC chromatogram of 
CRAE D. The HPLC chromatogram of berberine reference standard. E. Standard calibration 
curve of berberine.
Figure 2. The photomicrography of liver sections from rats treated with CCl4, the post-doses 
of CRAE at 400, 600 and 800 mg/kg BW, and olive oil vehicle. A. liver section of normal rat; 
B. liver section of the control rat treated with CCl4; C. liver section of the CCl4-treated rat 
post-dosed by CRAE at 800 mg/kg BW; D. liver section of the CCl4-treated rat post-dosed by 
CRAE at 600 mg/kg BW; E. liver section of the CCl4-treated rat post-dosed by CRAE at 400 
mg/kg BW; F. liver section of the CCl4-treated rat post-dosed by berberine at 120 mg/kg BW.
